Protecting our value through IP
AMADIX recognizes the importance of developing IP strategies early to determine how it could serve our long-term business interests. We capture the value of our innovation through strong patent protection.
Our Products
PreveCol®
Innovative blood-based test for colorectal cancer detection based on a biomarker signature.
DiagnoLung®
Innovative non-invasive signature for lung cancer diagnosis. It can be used for Lung Cancer diagnostics and as a tool for screening a high-risk population.
PancreaDix®
Innovative non-invasive signature in blood for the detection of pancreatic cancer (ductal adenocarcinoma (PDAC) and preneoplastic lesions).
